PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice.

Saved in:
Bibliographic Details
Title: PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice.
Authors: Burger DR; CytoDyn Inc., Immunology, Vancouver, Washington. Electronic address: dburger@cytodyn.com., Parker Y; Department of Translational Biology and Oncology Research, The Cleveland Clinic Main Campus, Cleveland, Ohio., Guinta K; Department of Translational Biology and Oncology Research, The Cleveland Clinic Main Campus, Cleveland, Ohio., Lindner D; Department of Translational Biology and Oncology Research, The Cleveland Clinic Main Campus, Cleveland, Ohio.
Source: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2018 Feb; Vol. 24 (2), pp. 260-266. Date of Electronic Publication: 2017 Nov 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Journal Info: Publisher: Carden Jennings Publishing Country of Publication: United States NLM ID: 9600628 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6536 (Electronic) Linking ISSN: 10838791 NLM ISO Abbreviation: Biol Blood Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first